Skip to main content
. 2023 Nov 14;326(2):G147–G162. doi: 10.1152/ajpgi.00184.2023

Table 5.

Demethylation of 5mCpG in promoter regions of chemical carcinogenesis-receptor activation pathway

Gene Name DMR Location in Promoter Region
DMR (Methylation %)
Chromosome Start End 3 h 6 h 12 h 24 h
BCL6 Chr24 187,455,336 187,455,954 −20.42 −43.30 −33.25 −31.52
CACNA1D Chr7 53,529,276 53,529,335 −55.12 −69.10 0.00 0.00
CREB3L4 Chr5 153,938,859 153,938,897 0.00 −36.38 0.00 −35.93
CYP1A1 Chr5 75,019,335 75,019,387 −30.07 −55.38 0.00 −27.04
ESR2 Chr14 64,751,715 64,751,757 0.00 −33.80 −28.97 −24.69
FGF8 Chr10 103,539,541 103,539,685 −19.97 −53.29 −37.87 0.00
MIR29A Chr7 130,562,558 130,562,743 −15.46 −32.98 −22.09 −26.93
MIRLET7B Chr22 46,508,476 46,508,565 0.00 −34.85 0.00 −24.75
MTOR Chr1 11,323,660 11,323,854 −20.34 −37.30 −27.13 0.00

Gene name represent the official gene symbol as recorded in NCBI database. Differentially methylated region (DMR) (methylation %) represents the percentage change in methylation levels induced by cholestenoic acid (CA) treatment at various time points compared with the control group. P = 0.0027 at 6 h.